{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T18:17:52Z","timestamp":1783189072914,"version":"3.54.6"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100014103","name":"Key Technology Research and Development Program of Shandong Province","doi-asserted-by":"publisher","award":["2021ZD0202900"],"award-info":[{"award-number":["2021ZD0202900"]}],"id":[{"id":"10.13039\/100014103","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014103","name":"Key Technology Research and Development Program of Shandong Province","doi-asserted-by":"publisher","award":["2025CXPT178"],"award-info":[{"award-number":["2025CXPT178"]}],"id":[{"id":"10.13039\/100014103","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014103","name":"Key Technology Research and Development Program of Shandong Province","doi-asserted-by":"publisher","award":["2024CXPT029"],"award-info":[{"award-number":["2024CXPT029"]}],"id":[{"id":"10.13039\/100014103","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014103","name":"Key Technology Research and Development Program of Shandong Province","doi-asserted-by":"publisher","award":["2021ZD0203500"],"award-info":[{"award-number":["2021ZD0203500"]}],"id":[{"id":"10.13039\/100014103","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai Municipality","doi-asserted-by":"publisher","award":["23ZR1474900"],"award-info":[{"award-number":["23ZR1474900"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai Municipality","doi-asserted-by":"publisher","award":["24ZR1413700"],"award-info":[{"award-number":["24ZR1413700"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82571743"],"award-info":[{"award-number":["82571743"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["25DX2800300"],"award-info":[{"award-number":["25DX2800300"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010040","name":"Taishan Scholar Project of Shandong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010040","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ejmech.2026.118964","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T06:09:35Z","timestamp":1778911775000},"page":"118964","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Discovery of a highly selective and potent kappa opioid receptor agonist from N-cyclopropylmethyl-7\u03b1-piperazinyl \u22126,14-endoethano-tetrahydronorthebaines"],"prefix":"10.1016","volume":"315","author":[{"given":"Shaoliang","family":"Duan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuliang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangwen","family":"Gui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denggao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobo","family":"Mai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songyu","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinggen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8449-3839","authenticated-orcid":false,"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.118964_bib1","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0370-20.2020","article-title":"\u03ba opioid receptor-dynorphin signaling in the central amygdala regulates conditioned threat discrimination and anxiety","volume":"8","author":"Baird","year":"2021","journal-title":"eNeuro"},{"key":"10.1016\/j.ejmech.2026.118964_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.837671","article-title":"The Kappa opioid receptor: a promising therapeutic target for multiple pathologies","volume":"13","author":"Dalefield","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118964_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fnsys.2022.963691","article-title":"Dynorphin\/kappa opioid receptor system regulation on amygdaloid circuitry: implications for neuropsychiatric disorders","volume":"16","author":"Limoges","year":"2022","journal-title":"Front. Syst. Neurosci."},{"key":"10.1016\/j.ejmech.2026.118964_bib4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.brainres.2018.09.023","article-title":"Dynorphin\/kappa-opioid receptor control of dopamine dynamics: implications for negative affective states and psychiatric disorders","volume":"1713","author":"Tejeda","year":"2019","journal-title":"Brain Res."},{"key":"10.1016\/j.ejmech.2026.118964_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114785","article-title":"A systematic review on the kappa opioid receptor and its ligands: new directions for the treatment of pain, anxiety, depression, and drug abuse","volume":"243","author":"Khan","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118964_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fpain.2023.960389","article-title":"The opioid receptor: emergence through millennia of pharmaceutical sciences","volume":"4","author":"Fairbanks","year":"2023","journal-title":"Front Pain Res"},{"key":"10.1016\/j.ejmech.2026.118964_bib7","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1021\/acsmedchemlett.2c00237","article-title":"Discovery of \u03ba opioid receptor (KOR)-selective D-Tetrapeptides with improved antinociceptive effect after peripheral administration","volume":"13","author":"Stefanucci","year":"2022","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.118964_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26164767","article-title":"In silico identification of tripeptides as lead compounds for the design of KOR ligands","volume":"26","author":"Stefanucci","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.118964_bib9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1358\/dof.2019.44.1.2885875","article-title":"kappa-Opioid receptor agonists in pain treatment","volume":"44","author":"Pergolizzi","year":"2019","journal-title":"Drug Future"},{"key":"10.1016\/j.ejmech.2026.118964_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28010346","article-title":"Design of \u03ba-Opioid receptor agonists for the development of potential treatments of pain with reduced side effects","volume":"28","author":"Santino","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.118964_bib11","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/s41386-018-0155-0","article-title":"Phosphoproteomic approach for agonist-specific signaling in mouse brains: mTOR pathway is involved in \u03ba opioid aversion","volume":"44","author":"Liu","year":"2019","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.ejmech.2026.118964_bib12","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1248\/cpb.46.366","article-title":"Discovery of a structurally novel opioid \u03ba-agonist derived from 4,5-epoxymorphinan","volume":"46","author":"Nagase","year":"1998","journal-title":"Chem Pharm Bull"},{"key":"10.1016\/j.ejmech.2026.118964_bib13","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.brainres.2003.09.057","article-title":"Effect of repeated administration of TRK-820, a kappa-opioid receptor agonist, on tolerance to its antinociceptive and sedative actions","volume":"995","author":"Suzuki","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.ejmech.2026.118964_bib14","doi-asserted-by":"crossref","first-page":"6271","DOI":"10.1016\/j.bmc.2015.08.036","article-title":"Synthesis of new opioid derivatives with a propellane skeleton and their pharmacologies: part 5, novel pentacyclic propellane derivatives with a 6-amide side chain","volume":"23","author":"Nakajima","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118964_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106091","article-title":"An updated assessment of the translational promise of G-protein-biased kappa opioid receptor agonists to treat pain and other indications without debilitating adverse effects","volume":"177","author":"French","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2026.118964_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.00407","article-title":"A review of the therapeutic potential of recently developed G protein-biased kappa agonists","volume":"10","author":"Mores","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118964_bib17","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1039\/D1MD00041A","article-title":"Comprehensive overview of biased pharmacology at the opioid receptors: biased ligands and bias factors","volume":"12","author":"De Neve","year":"2021","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118964_bib18","doi-asserted-by":"crossref","first-page":"eaav0320","DOI":"10.1126\/scisignal.aav0320","article-title":"Biased ligands at opioid receptors: current status and future directions","volume":"14","author":"Che","year":"2021","journal-title":"Sci. Signal."},{"key":"10.1016\/j.ejmech.2026.118964_bib19","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aai8441","article-title":"Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria","volume":"9","author":"Brust","year":"2016","journal-title":"Sci. Signal."},{"key":"10.1016\/j.ejmech.2026.118964_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2022.173394","article-title":"The G-protein biased kappa opioid agonists, triazole 1.1 and nalfurafine, produce non-uniform behavioral effects in male rhesus monkeys","volume":"217","author":"Huskinson","year":"2022","journal-title":"Pharmacol Biochem Be"},{"key":"10.1016\/j.ejmech.2026.118964_bib21","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1111\/bph.13854","article-title":"Selective \u03ba receptor partial agonist HS666 produces potent antinociception without inducing aversion after i.c.v. administration in mice","volume":"174","author":"Spetea","year":"2017","journal-title":"Brit J Pharmacol"},{"key":"10.1016\/j.ejmech.2026.118964_bib22","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1124\/jpet.114.216820","article-title":"The G protein-biased \u03ba-Opioid receptor agonist RB-64 is analgesic with a unique spectrum of activities in vivo","volume":"352","author":"White","year":"2015","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.ejmech.2026.118964_bib23","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1124\/jpet.118.255661","article-title":"Preclinical testing of nalfurafine as an opioid-sparing adjuvant that potentiates analgesia by the Mu opioid receptor-targeting agonist morphine","volume":"371","author":"Kaski","year":"2019","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.ejmech.2026.118964_bib24","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cellsig.2017.01.016","article-title":"Nalfurafine is a G-protein biased agonist having significantly greater bias at the human than rodent form of the kappa opioid receptor","volume":"32","author":"Schattauer","year":"2017","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ejmech.2026.118964_bib25","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1021\/acschemneuro.9b00195","article-title":"Signaling properties of structurally diverse kappa opioid receptor ligands: toward in vitro models of in vivo responses","volume":"10","author":"Dunn","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2026.118964_bib26","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1021\/acschemneuro.0c00407","article-title":"Comparison of pharmacological properties between the kappa opioid receptor agonist nalfurafine and 42B, its 3-Dehydroxy analogue: disconnect between agonist bias and pharmacological effects","volume":"11","author":"Cao","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2026.118964_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/molecules30030604","article-title":"Effects of biased analogues of the kappa opioid receptor agonist, U50,488, in preclinical models of pain and side effects","volume":"30","author":"van de Wetering","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.118964_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2024.110061","article-title":"Limitations and potential of \u03baOR biased agonists for pain and itch management","volume":"258","author":"El Daibani","year":"2024","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2026.118964_bib29","first-page":"431","article-title":"G protein signaling-biased kappa opioid receptor agonists produce anxiolytic-like effects in mice","volume":"49","author":"Bohn","year":"2024","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.ejmech.2026.118964_bib30","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1124\/jpet.120.000134","article-title":"Strategies for developing kappa opioid receptor agonists for the treatment of pain with fewer side effects","volume":"375","author":"Paton","year":"2020","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.ejmech.2026.118964_bib31","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1007\/s40265-021-01619-6","article-title":"Difelikefalin: first approval","volume":"81","author":"Deeks","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.ejmech.2026.118964_bib32","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1177\/10600280221115889","article-title":"Difelikefalin: a new \u03ba-Opioid receptor agonist for the treatment of hemodialysis-dependent chronic kidney disease-associated pruritus","volume":"57","author":"Fugal","year":"2023","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.ejmech.2026.118964_bib33","first-page":"291","article-title":"Syntheses of 7\u03b1-aryl-6,14-endoetheno-tetrahydrothebaine","volume":"26","author":"Qiu","year":"1995","journal-title":"Chin. J. Pharm."},{"key":"10.1016\/j.ejmech.2026.118964_bib34","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1007\/s00044-010-9471-6","article-title":"Synthesis and evaluation of kappa-opioid receptor agonistic activity and antinociceptive effect of novel morphine analogues, 7 alpha-phenyl-6 alpha,14 alpha-endo-etheno-tetrahydrothebaine with substituted o-, m- and p-amino group","volume":"20","author":"Qi","year":"2011","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2026.118964_bib35","doi-asserted-by":"crossref","first-page":"11054","DOI":"10.1021\/acs.jmedchem.9b00857","article-title":"Discovery of a highly selective and potent kappa opioid receptor agonist from N-Cyclopropylmethyl-7alpha-phenyl-6,14-endoethanotetrahydronorthebaines with reduced central nervous system (CNS) side effects navigated by the message-address concept","volume":"62","author":"Xiao","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118964_bib36","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1038\/s41401-021-00761-x","article-title":"Novel selective kappa agonists SLL-039 and SLL-1206 produce potent antinociception with fewer sedation and aversion","volume":"43","author":"Wei","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejmech.2026.118964_bib37","doi-asserted-by":"crossref","first-page":"15889","DOI":"10.1021\/acs.jmedchem.5c00882","article-title":"Structure-activity relationship of N-Cyclopropylmethyl-7alpha-[para-(arylcarboxamido)phenyl]-6,14-endoethano-tetrahydronorthebaines as potent and selective kappa opioid receptor agonists","volume":"68","author":"Kong","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118964_bib38","doi-asserted-by":"crossref","first-page":"12414","DOI":"10.1021\/acs.jmedchem.1c01082","article-title":"Discovery of an M-Substituted N-Cyclopropylmethyl-7alpha-phenyl-6,14-endoethanotetrahydronorthebaine as a selective, potent, and orally active kappa-Opioid receptor agonist with an improved central nervous system safety profile","volume":"64","author":"He","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118964_bib39","doi-asserted-by":"crossref","first-page":"10377","DOI":"10.1021\/acs.jmedchem.2c00014","article-title":"SLL-627 is a highly selective and potent kappa opioid receptor (KOR) agonist with an unexpected nonreduction in locomotor activity","author":"Kong","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118964_bib40","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1021\/acschemneuro.6b00321","article-title":"The pharmacological heterogeneity of nepenthone analogs in conferring highly selective and potent kappa-Opioid agonistic activities","volume":"8","author":"Li","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2026.118964_bib41","doi-asserted-by":"crossref","first-page":"7112","DOI":"10.1021\/acs.jmedchem.3c02439","article-title":"Discovery of an ortho-substituted N-Cyclopropylmethyl-7alpha-phenyl-6,14-endoethano-tetrahydronorthebaine derivative as a selective and potent kappa opioid receptor agonist with subsided sedative effect","volume":"67","author":"Li","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118964_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2026.118591","article-title":"Structure-activity relationship of N-cyclopropylmethyl-7\u03b1-(m-methyl aminophenyl)-6,14-endoethano-northebaine derivatives as G-protein-biased kor-selective agonists","volume":"306","author":"Tang","year":"2026","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118964_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2025.118373","article-title":"Design, synthesis, and biological activity of novel-substituted phenylamino and phenyl derivatives of northebaine as selective delta opioid receptor agonists","volume":"130","author":"Zhang","year":"2025","journal-title":"Bioorgan Med Chem"},{"key":"10.1016\/j.ejmech.2026.118964_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115589","article-title":"Reversal of subtype-selectivity and function by the introduction of a para-benzamidyl substituent to N-cyclopropylmethyl nornepenthone","volume":"258","author":"Kong","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118964_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117449","article-title":"Structure-activity relationship analysis of meta-substituted N-cyclopropylmethyl-nornepenthones with mixed KOR\/MOR activities","volume":"289","author":"Tang","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118964_bib46","first-page":"371","article-title":"Synthesis of the new thebaine derivatives by the diels-alder reaction with northebaine","volume":"32","author":"Kim","year":"1988","journal-title":"J. Kor. Chem. Soc."},{"key":"10.1016\/j.ejmech.2026.118964_bib47","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ejphar.2008.02.028","article-title":"LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential","volume":"584","author":"Tao","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118964_bib48","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.bmcl.2009.07.119","article-title":"Highly selective and potent mu opioid ligands by unexpected substituent on morphine skeleton","volume":"20","author":"Li","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.ejmech.2026.118964_bib49","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2147\/IJNRD.S145720","article-title":"Post-marketing surveillance study of the safety and efficacy of nalfurafine hydrochloride (Remitch (R) capsules 2.5 mu g) in 3,762 hemodialysis patients with intractable pruritus","volume":"11","author":"Kozono","year":"2018","journal-title":"Int J Nephrol Renov"},{"key":"10.1016\/j.ejmech.2026.118964_bib50","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2147\/HMER.S352775","article-title":"Post-marketing surveillance study of the safety and efficacy of nalfurafine (capsules 2.5 mu g, oral dispersing tablets 2.5 mu g) in 1186 patients with chronic liver disease and intractable pruritus","volume":"14","author":"Yoshitani","year":"2022","journal-title":"Hepatic Med-Evid Res"},{"key":"10.1016\/j.ejmech.2026.118964_bib51","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0014-2999(99)00369-6","article-title":"Pharmacological properties of TRK-820 on cloned \u03bc-, \u03b4- and \u03ba-opioid receptors and nociceptin receptor","volume":"376","author":"Seki","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118964_bib52","doi-asserted-by":"crossref","first-page":"8872","DOI":"10.1021\/jm401290y","article-title":"Synthesis and pharmacological evaluation of aminothiazolomorphinans at the Mu and kappa opioid receptors","volume":"56","author":"Provencher","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118964_bib53","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.cell.2017.12.011","article-title":"Structure of the nanobody-stabilized active state of the kappa opioid receptor","volume":"172","author":"Che","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2026.118964_bib54","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1749-6632.1977.tb41843.x","article-title":"ACTH: a short introductory review","volume":"297","author":"Schwyzer","year":"1977","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ejmech.2026.118964_bib55","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1021\/jm00157a018","article-title":"Peptides as receptor selectivity modulators of opiate pharmacophores","volume":"29","author":"Lipkowski","year":"1986","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118964_bib56","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1021\/jm00168a028","article-title":"Design of peptidomimetic delta-opioid receptor antagonists using the message address concept","volume":"33","author":"Portoghese","year":"1990","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118964_bib57","first-page":"9","article-title":"The molecular-basis of the pharmacological action of alpha-cao, Asia pac","volume":"5","author":"Liu","year":"1990","journal-title":"J. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118964_bib58","first-page":"335","article-title":"Pharmacological study of an irreversible partial agonist of opiate receptors, a-Alpha-Cao","volume":"32","author":"Li","year":"1989","journal-title":"Sci. China, Ser. B"},{"key":"10.1016\/j.ejmech.2026.118964_bib59","first-page":"118","article-title":"Pharmacological study on an irreversible ligand of opioid receptors- 7 alpha-bis (beta-chloroethyl) amino-6, 14-endoetheno-tetrahydrooripavine (alpha-CAO)","volume":"9","author":"Li","year":"1987","journal-title":"Acta Acad. Med. Sin."},{"key":"10.1016\/j.ejmech.2026.118964_bib60","first-page":"812","article-title":"Studies on irreversible binding opioid receptor agonists and antagonists. I. Synthesis of 7 alpha-amino-6, 14-endoetheno-tetrahydrooripavine derivatives","volume":"19","author":"Qiu","year":"1984","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.ejmech.2026.118964_bib61","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s00894-005-0084-9","article-title":"3D-QSAR studies of orvinol analogs as \u03ba-opioid agonists","volume":"12","author":"Li","year":"2006","journal-title":"J. Mol. Model."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426004095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426004095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T17:49:30Z","timestamp":1783187370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426004095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":61,"alternative-id":["S0223523426004095"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118964","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of a highly selective and potent kappa opioid receptor agonist from N-cyclopropylmethyl-7\u03b1-piperazinyl \u22126,14-endoethano-tetrahydronorthebaines","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118964","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118964"}}